Post-earnings recap
Reported
Wed, Feb 24, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's earnings report shows a significant miss on EPS, leading to a slight decline in stock price by 0.57%. The lack of revenue figures and guidance adds to investor uncertainty. The company is facing challenges that may impact its performance in the near future.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-3.07 | N/A | -1123.11% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed concerns about the current market environment. They did not provide any forward-looking guidance, indicating uncertainty.
Management did not provide specific guidance for future quarters.
The company acknowledged challenges in meeting market expectations.